Tången Industrikapital AB (Ticker: TANGENB SS) is a Swedish industrial investment group that owns and develops Nordic companies with a long-term, active majority-ownership approach. The company is domiciled in Sweden and focuses on three business areas: Regulatory Expertise, Service Solutions and Industrial Technology. Its portfolio companies operate independently, while Tången supports them with industrial expertise, financial discipline and add-on acquisition capabilities.

Tången plans to list on Nasdaq Stockholm on June 12, 2026. According to published terms, the company is offering 15.47 million B shares at SEK 67.00 per share, raising approximately SEK 1.04 billion, or about $111 million. The IPO implies a post-listing market capitalization of around SEK 3.8 billion, or approximately $406 million.

The offering consists of approximately 5.97 million primary shares and 9.50 million secondary shares. The company is expected to receive about SEK 400 million before issue costs, primarily to fund future acquisitions. Anchor investors including Andra AP-fonden, Handelsbanken Fonder, Protean Funds and Svolder have committed to subscribe for shares totaling SEK 470 million. DNB Carnegie and Nordea are listed as managers.

Space Exploration Technologies Corp. (Ticker: SPCX US), known as SpaceX, is an American company that designs, manufactures, launches and operates rockets, spacecraft, satellite networks and related software infrastructure. The company is domiciled in the United States and is incorporated in Texas.

SpaceX plans to list on NASDAQ on June 12, 2026. According to published terms, the company plans to offer 555.56 million shares at $135.00 per share, raising approximately $75.0 billion - the largest IPO in history. The company operates across space launch services, Starlink satellite broadband connectivity and AI infrastructure. As of March 31, 2026, SpaceX reported approximately 9,600 Starlink broadband and mobile satellites in low-Earth orbit, serving about 10.3 million Starlink subscribers across 164 countries, territories and other markets.

According to the prospectus, SpaceX acquired xAI in early 2026, making it an integral part of the company’s vertically integrated structure alongside SpaceX’s launch, connectivity and AI capabilities. For the 12 months ended March 31, 2026, SpaceX reported revenue of approximately $19.3 billion and a net loss of approximately $8.7 billion.

InstallatørGruppen A/S (Ticker: IG DC) is a Danish provider of multi-disciplinary technical installation services, operating in Denmark and Switzerland through a decentralized network of locally anchored portfolio companies. The company provides installation, service and maintenance of technical systems across residential, commercial, industrial and public-sector end markets, including electrical installations, heating, ventilation, cooling, building automation, solar installations and fire safety solutions.

InstallatørGruppen plans to list on Nasdaq Copenhagen on June 11, 2026. According to published terms, the company is offering 70.0 million existing shares at DKK 15.00 per share, raising DKK 1.05 billion, or approximately $163 million. The implied market value at the offer price is DKK 4.5 billion, or approximately $698 million.

The offering consists entirely of secondary shares sold by FSN Capital-related funds and around 300 minority shareholders, so the company is not expected to receive IPO proceeds. The selling shareholders have granted a 15% overallotment option of up to 10.5 million additional shares, which would increase the offering to DKK 1.2 billion if exercised in full. The group was established in 2023 and has completed 47 acquisitions.

Forbright (Ticker: FRBT US) is an American digital-first bank and commercial lender specializing in sustainable finance, with services spanning nationwide middle-market lending, digital consumer banking, strategic advisory and asset management. The company is domiciled in the United States and traces its history to Congressional Bank, established in 2003, before a period of growth and modernization beginning in 2020 and a rebranding to Forbright following a $369 million capital infusion in 2021.

Forbright plans to list on NASDAQ on June 11, 2026. According to published terms, the company plans to offer 7.9 million shares at a price range of $18.00 to $20.00 per share, raising approximately $150 million at the $19.00 midpoint. The estimated market capitalization is approximately $944 million.

For the 12 months ended March 31, 2026, Forbright reported revenue of approximately $334 million and net income of approximately $88 million. Goldman Sachs, J.P. Morgan, Barclays, Wells Fargo Securities, Piper Sandler, TD Securities, Santander and Centerview Partners are listed as joint bookrunners.

Apotex Health Corp (Ticker: APTX CN) is a Canadian pharmaceutical company focused on generic drugs and consumer health products. The Toronto-based company manufactures more than 800 pharmaceutical and consumer health products, serves customers in about 70 countries and employs over 6,000 people worldwide. Apotex Health listed on the Toronto Stock Exchange on June 10, 2026, offering 54.17 million common shares at CAD 24.00 per share, at the top of the amended CAD 20.00–24.00 range, raising CAD 1.30 billion, approximately $943 million.

According to published terms, the upsized offering consisted of 35.42 million primary shares and 18.75 million secondary shares, with a 15% greenshoe facility. The IPO was managed by BMO Capital Markets, Jefferies Securities, RBC Capital Markets, Scotiabank and TD Securities. Reuters reported that the transaction was the largest Toronto stock market IPO since 2021. Apotex was owned by New York private equity firm SK Capital Partners before the IPO, and SK Capital is expected to remain the majority shareholder after the listing.

Parabilis Medicines (Ticker: PBLS US) is an American clinical-stage biotechnology company developing engineered peptide therapies for cancer. The company is domiciled in the United States and uses its proprietary Helicon platform to produce helical peptides designed to modulate intracellular protein interactions that are not accessible to small-molecule therapies or biologic drugs.

Parabilis plans to list on NASDAQ on June 10, 2026. According to published terms, the company plans to offer 25.0 million shares at a price range of $17.00 to $19.00 per share, raising approximately $450 million at the $18.00 midpoint. The estimated market capitalization is around $2.6 billion.

The company’s lead drug candidate, zolucatetide, targets the Wnt/β-catenin pathway, which is associated with a broad range of solid tumors. Parabilis is evaluating zolucatetide in ongoing clinical trials across multiple indications, including desmoid tumors and familial adenomatous polyposis. The company plans to start a Phase 3 registrational trial in desmoid tumors in the first half of 2027. Parabilis has not generated product revenue to date and reported a net loss of approximately $153 million for the 12 months ended March 31, 2026.

ERock, Inc. (Ticker: EROC US) is an American company that designs, deploys, operates and maintains modular distributed natural gas power generation systems, supported by proprietary low-emission generator technology and embedded software. The company is domiciled in the United States and primarily serves data centers, utilities and large commercial and industrial customers across nine U.S. states.

ERock plans to list on the NYSE on June 10, 2026. According to published terms, the company plans to offer 27.9 million shares at a price range of $20.00 to $23.00 per share, raising approximately $600 million at the $21.50 midpoint. The estimated market capitalization is around $4.7 billion. ERock’s systems are used for bridge power, backup resiliency and dispatchable flexible-capacity applications, with major operating footprints in California and Texas. As of March 31, 2026, the company reported over 2,000 deployed units across about 400 operational sites, an installed base of approximately 1,000 MW and contracted power system sales backlog of approximately $1.3 billion.

Piece Peace Studio Co Ltd (Ticker: 0117P0 KS) is a South Korean apparel and fashion company operating designer and contemporary lifestyle brands, including Mardi Mercredi and Hello Sunrise. The company sells tops, sweatshirts, shirts, sweaters, shoes, kidswear and related apparel products, and distributes through its own online channels, flagship stores and other retail networks, with operations focused in South Korea and expansion into overseas markets including Japan.

Piece Peace Studio plans to list on KOSDAQ on June 8, 2026. According to published terms, the company is offering 2.27 million common shares at KRW 21,500 per share, raising approximately KRW 48.9 billion, or about $33 million. The IPO includes 2.10 million new shares, representing 92.4% of the offering, and 172,637 secondary shares, representing 7.6%. NH Investment & Securities and Mirae Asset Securities are the offering managers.

WhiteHawk Minerals (Ticker: WHK US) is an American company focused on acquiring and managing high-quality natural gas mineral and royalty interests in premier U.S. basins. The company’s portfolio is concentrated in the Appalachian and Haynesville Basins and, as of December 31, 2025, spanned approximately 3.4 million gross DSU acres.

WhiteHawk plans to list on the NYSE on Friday, June 5, 2026, with pricing expected after market close on Thursday, June 4, 2026. According to published terms, the company is offering 6,925,000 shares at a price range of $25.00 to $27.00 per share, implying an IPO offer size of approximately $180 million.

The offering is structured as 100% primary shares. Raymond James, Stifel and J.P. Morgan are acting as bookrunners, with Raymond James also serving as stabilization agent and bill and deliver bank.

Lung Fung Group Holdings Limited (Ticker: 2290 HK) is a Hong Kong-based retailer of beauty, health and pharmaceutical products, operating under the “Lung Fung” brand through 31 retail stores in Hong Kong and online sales platforms. The company is domiciled in Hong Kong and offers products across categories including proprietary Chinese medicines, western medicines, health supplements, skincare, cosmetics, fragrances, personal care, maternal and infant products, food, pet food and household daily necessities.

Lung Fung Group plans to list on the Hong Kong Stock Exchange on June 5, 2026. According to published terms, the company is offering 125.0 million primary shares at HKD 5.18-6.38 per share, raising up to approximately HKD 798 million, or about $102 million. The implied market capitalization is HKD 2.59-3.19 billion, equivalent to approximately $331-407 million.

According to the prospectus, IPO proceeds are expected to be used for R&D and product capacity, brand promotion and business development, working capital, strategic acquisitions, and other purposes. The offering includes a 15% greenshoe option and DBS Asia Capital is the sponsor.

Dajin Heavy Industry Co., Ltd. (Ticker: 1081 HK) is a Chinese company manufacturing and selling wind power equipment, including wind turbine frames, offshore wind foundations, offshore wind turbine infrastructure, thermal boiler island steel structures, and offshore oil and gas rig industrial structures. The company is domiciled in China and operates globally, with a focus on offshore wind power equipment R&D and manufacturing, heavy marine transportation, wind and photovoltaic power generation, and wind marshalling port operations.

Dajin plans to list H shares on the Hong Kong Stock Exchange on June 5, 2026. According to published terms, the company is offering 86.97 million primary H shares at HKD 66.40 per share, raising approximately HKD 5.8 billion, or about $737 million. The Bloomberg screen indicates market capitalization of approximately HKD 61.6 billion, equivalent to around $7.9 billion.

According to the prospectus, proceeds are expected to be used for R&D and production capacity, brand promotion and business development, working capital, strategic acquisitions, and other purposes. Dajin has been listed on the Shenzhen Stock Exchange since 2010, and founder Jin Xin is its largest shareholder.

LongBio Pharma (Suzhou) Co., Ltd. (Ticker: 1779 HK) is a Chinese clinical-stage biopharmaceutical company focused on in-house discovery and development of biologic treatments for allergic and autoimmune diseases. Its pipeline includes LP-003, an anti-IgE antibody targeting allergic rhinitis, chronic spontaneous urticaria, allergic asthma and other allergic diseases, and LP-005, a bi-functional antibody fusion protein targeting C5 and C3b complement for renal and hematologic indications. The company is domiciled in China.

LongBio Pharma plans to list H shares on the Hong Kong Stock Exchange on June 5, 2026. According to published terms, the company is offering 14.19 million primary H shares at HKD 96.06 per share, raising approximately HKD 1.36 billion, or about $174 million. The market capitalization at offer is indicated at approximately HKD 7.01 billion, equivalent to around $894 million.

According to the prospectus, IPO proceeds are expected to be used for R&D and product capacity, as well as working capital and strategic acquisitions. The offering consists entirely of primary shares and includes a 15% greenshoe option.

Quantinuum (Ticker: QNT US) is an American quantum computing systems and software developer incorporated in Delaware. The company offers a hardware-led, software-enhanced platform including quantum hardware, middleware, developer tools and applications for enterprise and government customers.

Quantinuum plans to list on NASDAQ on Thursday, June 4, 2026, with pricing expected after market close on Wednesday, June 3, 2026. According to updated published terms, Quantinuum has upsized its IPO to 26.5 million shares, up from 21.05 million shares, and raised the price range to $53.00 to $55.00 per share, up from $45.00 to $50.00. At the $54.00 midpoint, the IPO is expected to raise approximately $1.43 billion. The offering implies an estimated market capitalization of around $14.3 billion.

The IPO is structured as 100% primary shares, meaning proceeds are expected to go to the company. Quantinuum was formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum and remains a controlled affiliate of Honeywell, which is expected to remain a strategic customer and partner after the offering.

Liftoff Mobile, Inc. (Ticker: LFTO US) is an American company operating an AI-powered platform for mobile app advertising, user acquisition and app monetization. Incorporated in Delaware, Liftoff provides technology used by app marketers to acquire users and by app publishers to monetize ad inventory; according to the filing, its platform connected to roughly 1.4 billion daily active users worldwide in the fourth quarter of 2025.

Liftoff Mobile plans to list on NASDAQ on June 4, 2026. According to published terms, the company plans to offer 19.0 million shares at a price range of $20.00 to $22.00 per share, raising approximately $399 million at the $21.00 midpoint. The offering implies an estimated market capitalization of around $3.9 billion. Goldman Sachs, Jefferies, Morgan Stanley, Barclays, RBC Capital Markets, UBS Investment Bank, Wells Fargo Securities and William Blair are among the lead underwriters. Liftoff revived its IPO plans with a new S-1 filing in April 2026 after withdrawing a prior IPO plan in February 2026.

INNIO Group Holding GmbH (Ticker: INIO US) is a Germany-headquartered distributed energy solutions provider delivering reliable, flexible, decentralized, modular and efficient power solutions. The company designs, manufactures and services high-performance power systems, such as gas engines, under its Jenbacher and Waukesha brands, serving applications including data centers, microgrids, grid stabilization, industrial energy and gas compression.

INNIO plans to list on NASDAQ on Thursday, June 4, 2026, with pricing expected after market close on Wednesday, June 3, 2026. According to published terms, the company is offering 75,000,000 shares at a price range of $24.00 to $27.00 per share, implying an IPO offer size of approximately $1.9 billion.

The offering is structured as 100% secondary shares, meaning proceeds are expected to go to selling shareholders rather than to the company. Goldman Sachs, J.P. Morgan and Morgan Stanley are acting as bookrunners.

Safepoint Holdings, Inc. (Ticker: SFPT US) is an American property and casualty insurance company focused on specialty homeowners and commercial property insurance in coastal markets, particularly Florida and Louisiana. The company, incorporated in Delaware, operates a mostly fee-based insurance servicing platform and had over $1.0 billion of in-force premiums as of December 31, 2025.

Safepoint plans to list on the NYSE on June 4, 2026, offering 16.7 million shares at $15.00 to $17.00 per share, raising approximately $267 million at the midpoint. The company’s estimated market capitalization is approximately $1.1 billion.

Founded in 2013, Safepoint combines policyholder-owned reciprocal insurance exchanges, which it manages as attorney-in-fact for a service fee, with its wholly owned insurance company, Safepoint Insurance. According to the prospectus, most of its in-force premium was originally placed with the reciprocal exchanges, while 11% was originally placed with Safepoint Insurance as of December 31, 2025. Safepoint is founder-led and majority-owned by management. Deutsche Bank Securities, Morgan Stanley, Keefe Bruyette Woods, Citizens Capital, Piper Sandler, Truist Securities and William Blair are joint bookrunners.

Sunshine Silver Mining & Refining, Inc. (Ticker: SSMR US) is an American development-stage mining company focused on restarting the historic Sunshine Mine and related refining facilities in Kellogg, Idaho. The company owns a historically producing silver mine whose byproducts include antimony, copper and lead, and owns or leases land in the Sunshine Mine Core Area, the Coeur d’Alene Mining District and the Lakeview Mining District.

Sunshine Silver Mining & Refining plans to list on the NYSE on June 4, 2026, offering 20.0 million shares at $13.50 to $16.50 per share, raising approximately $300 million at the midpoint. The company is incorporated in Delaware and has an estimated market capitalization of approximately $2.1 billion.

Founded in 2010, Sunshine Silver Mining & Refining acquired the Sunshine Mine that year and has not yet generated operating revenue. The company is maintaining and modernizing the site as it prepares for a targeted 2028 restart of mining, milling and refining operations. Morgan Stanley, Scotia Capital, BMO Capital Markets, Canaccord Genuity, Citigroup and RBC Capital Markets are joint bookrunners.

Applied Aerospace & Defense, Inc. (Ticker: AADX US) is an American aerospace and defense manufacturing company providing design, engineering and vertically integrated manufacturing services for mission-critical subsystems. The company serves three core markets: space and launch systems, defense aviation and airborne systems, and C5ISR and precision strike systems.

Applied Aerospace & Defense plans to list on the NYSE on June 3, 2026, offering 32.5 million shares at $18.00 to $21.00 per share, raising approximately $634 million at the midpoint. The company is incorporated in Delaware and has an estimated market capitalization of approximately $3.3 billion.

The company was created in December 2025 through the merger of PCX Aerosystems, whose roots date to 1900, and Applied Aerospace, founded in 1954. According to the prospectus, Applied Aerospace & Defense supplies highly engineered systems for leading and next-generation space and defense technology companies, with sole- or single-source positions representing about 87% of revenue for the fiscal year ended December 31, 2025. Morgan Stanley, Jefferies, BofA Securities, RBC Capital Markets, Guggenheim Securities, Baird, Stifel, WR Securities and Nomura Securities are joint bookrunners.

Beijing Shougang Lanzatech Technology Co., Ltd. (Ticker: 2553 HK) is a Chinese company operating in the CCUS industry, producing low-carbon products such as ethanol and microbial protein through carbon capture and utilization technologies, while also providing low-carbon integrated solutions. The company is domiciled in China and has commissioned four large-scale production facilities across China.

Shougang Lanzatech plans to list on the Hong Kong Stock Exchange on June 3, 2026. According to published terms, the company is offering 40.0 million H shares at HKD 14.60-17.10 per share, raising up to approximately HKD 684 million, or about $87 million. The implied market capitalization is HKD 5.84-6.84 billion, equivalent to approximately $745-873 million.

The IPO consists entirely of primary shares, with a 15% greenshoe option. According to the prospectus, proceeds are expected to be used for R&D and production capacity, brand promotion and business development, working capital, and strategic acquisitions. Shougang Group is a major shareholder, alongside LanzaTech Hong Kong Limited and other investors.

Shenzhen Creality 3D Technology Co Ltd (Ticker: 3388 HK) is a Chinese company focused on consumer 3D printing products and services, including 3D printers, 3D printing consumables, 3D scanners, laser engravers, accessories and services offered through its Creality Cloud platform.

Creality plans to list H shares on the Hong Kong Stock Exchange Main Board on May 29, 2026. According to published terms, the company is offering 73.43 million primary shares at HKD 18.80 per share, raising approximately HKD 1.38 billion, or about $176 million. The implied market capitalization at offer is approximately HKD 8.78 billion, or around $1.1 billion.

According to the prospectus, IPO proceeds are expected to be used for R&D and product capacity, brand promotion and business development, working capital and strategic acquisitions. China International Capital Corporation Hong Kong Securities Limited is the sponsor, with underwriters including ABCI Securities, BOCI Asia, CCB International, Deutsche Bank Hong Kong and others.

BioMar Group A/S (Ticker: BIOTEMP DC) is a Danish aquaculture company specializing in feed for farmed fish and shrimp. BioMar listed on Nasdaq Copenhagen on May 28, 2026, pricing its shares at DKK 108 each and raising DKK 3.13 billion, approximately $485 million, including the overallotment shares. The offer price valued the company at DKK 10.85 billion, or around $1.7 billion.

According to published terms, the IPO comprised 28.94 million shares including the overallotment option, with 463,000 new primary shares sold by BioMar and 24.7 million secondary shares sold by its parent company, Aktieselskabet Schouw & Co. BioMar raised DKK 50 million in gross primary proceeds, while it did not receive proceeds from Schouw & Co.’s sale of existing shares. Schouw & Co. is expected to remain BioMar’s majority shareholder following the IPO. The offering was reportedly Denmark’s largest IPO since 2018.

Viewtrix Technology Co., Ltd. (Ticker: 3310 HK) is a Chinese display technology company focusing on the design and sale of branded AMOLED display driver ICs and Micro-OLED display backplanes/drivers for smartphones and VR/AR devices. The company operates a fabless business model and manages its business in China, serving display panel manufacturers and major global and Chinese smartphone brands.

Viewtrix plans to list on the Hong Kong Stock Exchange Main Board on May 27, 2026, offering 52.86 million H shares at HKD 20.81 per share. The IPO is expected to raise approximately HKD 1.10 billion, or about $140 million, with an estimated market capitalization at offer of around $1.1 billion. The offering consists entirely of primary shares, with a 15% greenshoe option.

According to the prospectus, IPO proceeds are intended for R&D and product capacity, working capital, and strategic acquisitions. Sponsors are China International Capital Corporation Hong Kong Securities Limited and CITIC Securities (Hong Kong) Limited.

Shenzhen SDMC Technology Co., Ltd. (Ticker: 901 HK) is a Chinese smart home products provider for enterprise customers, developing and selling digital video devices, network communication devices, and related system platforms. The company’s products include media streaming terminals, projectors, cameras, Wi-Fi routers, optical network terminals and cable modems.

SDMC plans to list on the Hong Kong Stock Exchange Main Board on May 27, 2026. According to the IPO terms, the company is offering 19.21 million H shares at HKD 32.80 per share, raising approximately HKD 630 million, or about USD 80 million. The implied market capitalization at the offer price is approximately USD 877 million.

According to the prospectus, SDMC plans to use the IPO proceeds for R&D and product capacity expansion, brand promotion and business development, working capital, and strategic acquisitions. The offering is structured as an H-share IPO, with 100% of the offered shares being primary shares. China Securities (International) Corporate Finance is the sponsor, with underwriters including ABCI, CCB International, CMB International and CNCB Hong Kong Capital.

Beijing DeepZero Technology Co., Ltd. (Ticker: 2723 HK) is a Chinese company providing intelligent marketing services to enterprises through AI-based advertising and data management products. The company’s flagship platforms include AlphaDesk for real-time advertising campaign execution and optimization, and AlphaData for customer data management and CRM analytics. It also launched Deep Agent in 2025, an enterprise AI agent product suite for marketing and sales use cases.

Beijing DeepZero plans to list H shares on the Hong Kong Stock Exchange Main Board on May 27, 2026. According to the published IPO terms, the company is offering 9.068 million shares at an indicative price range of HKD 43.50-55.50 per share, raising approximately HKD 503 million, or about $64 million. The implied market capitalization at the offer range is approximately HKD 3.9-5.0 billion, or around $504-643 million.

The IPO consists entirely of primary shares. Proceeds are expected to be used for R&D and product capacity, brand promotion and business development, working capital, and strategic acquisitions.

TenNor Therapeutics (Suzhou) Limited (Ticker: 6872 HK) is a China-domiciled biotechnology company developing therapies for bacterial infections and diseases associated with bacterial metabolism. The company’s pipeline includes seven programs, including rifasutenizol (TNP-2198), which is being developed for H. pylori infection, bacterial vaginosis and C. difficile infection, and rifaquizinone (TNP-2092 injection), which is being developed for implant-associated bacterial infections and bloodstream-related infections.

TenNor Therapeutics is expected to list H shares on the Hong Kong Stock Exchange Main Board on May 22, 2026. According to published terms, the company is offering 8.28 million shares at HKD 75.70 per share, raising approximately HKD 627 million, or about $80 million. The market capitalization at the offer price is approximately $500 million.

The IPO consists entirely of primary shares and includes a 15% greenshoe option. According to the prospectus, the company plans to use the proceeds for R&D and product capacity, brand promotion and business development, working capital, and strategic acquisitions. CITIC Securities (Hong Kong) and ABCI Capital are sponsors of the offering.

Skinkandy Ltd (Ticker: SK1 AU) is an Australian retail company operating a chain of body piercing studios and selling related jewellery and aftercare products. The company plans to list on the Australian Securities Exchange on May 21, 2026, offering shares at AUD 2.20 and raising AUD 160 million, approximately $115 million. The IPO values the business at about AUD 245 million, or approximately $177 million. SkinKandy operates more than 100 piercing studios across Australia and New Zealand and is positioning itself as a lifestyle and jewellery retailer focused on younger consumers. According to published terms, the company will raise AUD 20 million in fresh capital, while existing shareholders, including private equity backer Whiteoak Capital, will reduce their holdings. Proceeds are expected to support SkinKandy’s offshore expansion plans, including entry into the United States, followed by potential expansion into the United Kingdom and South Africa. The IPO is underwritten by Barrenjoey Markets and Morgans Corporate.

UISEE Technologies (Beijing) Co., Ltd. (Ticker: 1511 HK) is a Beijing-based autonomous driving technology company focused on intelligent driving solutions. The company specializes in driverless L4 autonomous driving technology in Greater China, with a focus on commercial vehicles in closed scenarios such as airports, factories, ports and mining areas, while also serving open-scenario applications including logistics, buses and other mobility use cases. Its offerings include L4 autonomous driving vehicles, autonomous driving kits, software solutions and leasing services.

UISEE Tech plans to list on the Hong Kong Stock Exchange on May 20, 2026. According to the IPO terms, the company is offering approximately 14.46 million H shares at HK$60.30 per share, raising approximately HK$872.0 million, or about US$111.4 million. Market capitalization at the offer price is approximately HK$7.64 billion, or about US$976.1 million. The offering consists entirely of primary shares, with 5% allocated to the Hong Kong public offer and 95% to the international placing. CITIC Securities Hong Kong is the sponsor, with BOCOM International Securities, China Galaxy International Securities Hong Kong, CLSA, DBS Asia Capital and Hong Tai Securities acting as global coordinators.

MakinaRocks Co Ltd (Ticker: 477850 KS) is a South Korean software company focused on industrial AI solutions. The company supplies vertical AI systems for industrial environments, including closed-network and other specialized settings, and offers its proprietary AI platform Runway, AI consulting, and related operating-system implementation services.

MakinaRocks plans to list on KOSDAQ on May 20, 2026. According to published terms, the company is offering 2.64 million new common shares at KRW 15,000 per share, raising KRW 39.5 billion, or approximately $26 million. The market capitalization at the offer price is estimated at around $175 million. The IPO consists entirely of primary shares, with no secondary shares or greenshoe facility indicated. Mirae Asset Securities is the lead manager, with Hyundai Motor Securities also participating.

Shanghai Top Numerical Control Technology Co., Ltd. (Ticker: 7688 HK) is a Shanghai-based intelligent manufacturing equipment company focused on high-end five-axis CNC machine tools and process solutions for China’s aviation and aerospace sector. The company researches, designs, manufactures and sells five-axis computerized numerical control machine tools, drilling and riveting robots, intelligent production line systems and related repair and maintenance services. Its products are used in aviation and aerospace manufacturing, as well as general industrial applications including automotive, energy, medical equipment, shipbuilding and die and mould manufacturing.

Shanghai Top Numerical Control plans to list on the Hong Kong Stock Exchange on May 20, 2026. According to the IPO terms, the company is offering approximately 65.33 million H shares at HK$26.39 per share, raising approximately HK$1.72 billion, or about US$220.2 million. Market capitalization at the offer price is approximately HK$9.80 billion, or about US$1.25 billion. The offering consists entirely of primary shares and includes a 15% greenshoe option. The Hong Kong public offer accounts for 10% of the global offering, with 90% allocated to the international placing. CCB International Capital and Guotai Junan Capital are the sponsors, with CCB International Capital and Guotai Junan Securities Hong Kong acting as global coordinators.

Lincoln International (Ticker: LCLN US) is a Chicago-based global independent investment banking advisory firm focused on the private capital markets. Founded in 1996 and headquartered in Chicago, Illinois, the firm advises private equity and private credit investors, private company owners and senior executives through M&A advisory, capital advisory, private funds advisory, valuations and other services. As of Dec. 31, 2025, Lincoln had approximately 1,400 professionals, including 161 managing directors, across more than 30 offices in 14 countries.

Lincoln plans to list on the NYSE on May 20, 2026. According to terms disclosed in its May 11, 2026 S-1/A filing, the company is offering approximately 21.05 million shares at a price range of $18.00 to $20.00 per share, raising approximately $400.0 million at the $19.00 midpoint. Estimated market capitalization is approximately $1.94 billion. Lincoln reported approximately $783.8 million of revenue and $214.1 million of net income for the year ended Dec. 31, 2025. Goldman Sachs, Morgan Stanley, BMO Capital Markets, Citizens Capital Markets and Evercore ISI are acting as joint bookrunners, with Keefe, Bruyette & Woods and Wolfe Nomura Alliance as co-managers.